Non Alcoholic Fatty Liver Disease (NAFLD) (Gastrointestinal) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Non Alcoholic Fatty Liver Disease - Drugs in Development, 2021, provides an overview of the Non Alcoholic Fatty Liver Disease (Gastrointestinal)...
Impact of COVID-19 on the Top Five European Soccer Leagues Summary Analysis of the impact COVID-19 has had on the top five European Soccer leagues Economic analysis on the cost of postponing domestic cup fixtures, including ticket prices and estimated losses. Scope -...
Anatomic Pathology Market Size ,Share & Trends Analysis Report By Application (Disease Diagnosis, Drug Discovery & Development), By Product & Services (Instruments, Consumables), By End Use, And Segment Forecasts, 2019 - 2025 The global anatomic pathology market size is expected to reach USD 23.3 billion by 2025,...
Inflammation of pertonitis, the lining of inner wall of abdomen is referred to as Peritonitis condition. It is an urgent medical condition and is highly infectious, with an estimated 10% mortality rates. Over 15 companies and universities are focusing on developing treatment options for Peritonitis. To assist investigators and...
Non Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Drug Development Pipeline Review, 2018 Summary Both NASH and NAFLD occur largely as a result of prolonged insulin resistance and obesity with approximately 80% of cases being diagnosed in overweight individuals. NASH...
A fluid management system is used to balance body fluid in order to prevent complications associated with undesired levels of fluid in the body. Additionally, today is also used in diagnosis of critical medical conditions relatively early. Fluid management systems perform functions such as fluid irrigation, fluid warming, fluid filtration,...